Bailard’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-63,400
Closed -$155K 772
2021
Q4
$155K Buy
+63,400
New +$155K ﹤0.01% 701